Atlas Trials

Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients

Clinical trial NCT07358520 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07358520
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Proteinuria
Start date
2026-01-28
Primary completion
2027-01-28
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.